BattleVet reviews the projected 3.8% VA disability compensation increase for 2027 and the VA's first use of Visualase laser ablation for focal epilepsy.
On August 28, 2026, Stars and Stripes reported a set of specific updates affecting veteran benefits, neurological healthcare, and daily routines. The VA Disability Group estimated that the 2027 VA disability compensation adjustment could reach 3.7% to 3.8%, offering a preliminary look at next year's payments. Meanwhile, the Department of Veterans Affairs announced its first use of Visualase, which is a minimally invasive laser-ablation procedure for focal epilepsy. The coverage also highlighted Navy Korean War veteran Ed T. Solomon, who is currently promoting his 2024 book, Cooking at 90: When You Hate the Kitchen.
These combined updates carry direct material impacts for veterans managing their finances and daily routines. The projected disability adjustment provides an early financial baseline for the coming year, allowing veterans to forecast their household budgets. While the compensation estimate is not an official government announcement, it sets realistic expectations for upcoming December payments. On the medical front, the new neurological procedure shows the VA is actively working to provide highly specialized treatments internally. This operational shift could eventually reduce the need for outside academic medical referrals, streamlining care for complex seizure disorders.
The financial and medical data from these reports offer clear reference points for veterans looking ahead. For context, the 2026 VA disability compensation rates reflected a 2.8% baseline increase. This adjustment placed the 2026 monthly compensation rate for a veteran rated 100% with no dependents at $3,938.58. Meanwhile, the current rate for a 70% rating sits at $1,808.45 per month.
If the projected 3.8% estimate is eventually adopted, calculations will shift upward. One published calculation suggests the 100% veteran-alone rate could rise to approximately $4,088.25 per month. That specific scenario would mean an increase of about $149.67 over the 2026 rate. However, other projections range from roughly 3.0% to 3.8%, making these numbers strictly illustrative until the official rate is published.
A percentage increase does not translate into the same exact dollar increase for every veteran across the board. Monthly compensation depends entirely on the specific disability rating and the current dependent status of the veteran. Published examples for 70%, 80%, 90%, and 100% ratings show distinctly different projected dollar changes. This means a veteran rated at 70% will see a much smaller absolute dollar increase than a veteran rated at 100%.
The 2027 compensation discussion is part of a broader inflation protection mechanism for veterans. Official material from the VA indicates that at least some benefit adjustments are tied to Social Security COLA percentages. Because the 2026 baseline increase was 2.8%, the 2027 estimates of roughly 3.7% to 3.8% would be materially higher if confirmed.
The medical data regarding the new epilepsy treatment provides another distinct statistical metric. Stars and Stripes cited a multiyear clinical study involving 167 subjects with drug-resistant focal epilepsy. The study began in 2017 and continued to follow patient outcomes over time. It found that up to 60% of these specific patients were eventually free from disabling seizures.
The Visualase procedure uses a fiber-optic catheter to deliver laser energy to targeted brain tissue. It provides a highly targeted alternative to conventional open surgery in selected cases. The system delivers laser ablation through a 3.2-millimeter hole in the skull. It relies on real-time MRI guidance to monitor tissue temperatures and protect surrounding brain structures.
Thirty-three-year Army veteran Robert Lindemann became the first patient in the VA system to undergo this specific treatment. He reportedly began experiencing seizures about five years before the procedure, and standard medication had not controlled his condition. Following the treatment, VA officials reported that Lindemann went home just two days after the procedure. He then stated that he felt great four days later.
Veterans should treat any 2027 compensation figure as a planning estimate rather than a guaranteed payment amount. The final percentage will dictate exact payment amounts, which will vary based on individual disability ratings and dependent status. The annual adjustment is expected to take effect December 1, 2026. However, exact timing requires confirmation from official VA schedules, so veterans should wait for official communications.
For those managing benefits, it is practical to use current ratings to estimate the potential effect of a COLA. Veterans should avoid relying on a single projected percentage because current forecasts differ across organizations. The VA Disability Group’s estimate is an advocacy group projection rather than an official government announcement. Veterans should rely on official VA communications and accredited representatives instead of treating these early estimates as final.
On the healthcare side, the introduction of Visualase creates a new conversation point for specific patients. Veterans experiencing medication-resistant focal seizures can now ask their VA care team about specialized evaluations. Dr. Garrett Banks, the VA neurosurgeon who performed Lindemann’s procedure, noted that the system can treat focal epilepsy with very little trauma. He explained that it aims to preserve cognitive abilities, dignity, and well-being.
Lindemann's case involved an Epilepsy Center of Excellence referral pathway. This indicates that complex cases may involve specialized VA evaluation before a procedural option is even considered. Patients considering this option should ask their doctors about their candidacy and the exact seizure type being treated. The procedure targets focal epilepsy specifically, so veterans with generalized epilepsy should not assume this exact treatment applies to them.
A veteran considering laser ablation should ask specific questions about the follow-up requirements and long-term medication plans. They should also discuss whether a formal referral to a VA Epilepsy Center of Excellence is the most appropriate next step. The available reporting supports these as reasonable decision topics for veterans managing their care. However, these reports do not provide individualized medical advice, making direct consultation with a specialist essential.
While early recovery reports are positive, veterans should distinguish short-term recovery information from long-term treatment effectiveness. The current reporting provides a short-term postoperative update for Lindemann. It does not report long-term seizure control, complications, or medication changes. Furthermore, the 60% study result comes from a separate multiyear study and should not be conflated with Lindemann’s personal outcome.
Finally, Solomon's cookbook offers a practical perspective on sustained health and daily activity with age. Ed T. Solomon, a Navy veteran and Korean War radar technician, focuses on accessible living through simple recipes, photographs, and humor. His book includes simple ideas like peanut-butter-and-mayonnaise sandwiches and canned soup enhanced with shredded cheese, croutons, and crackers. This highlights how veterans can maintain daily routines and independence without complicated cooking habits.
The cookbook was published in 2024, and it is explicitly aimed at people who simply do not enjoy cooking. Solomon's project can be framed as an excellent example of veteran creativity and accessible living. The available search evidence does not independently verify the cookbook’s sales performance or commercial success beyond the Stars and Stripes report. Still, it presents continued creative activity and practical independence as a vital part of everyday veteran life.
The Michael E. DeBakey VA Medical Center in Houston performed this initial laser-ablation procedure. The operation utilized a multidisciplinary team involving neurosurgery, neurology, and radiology. This collaboration marks a clear milestone in federal veteran healthcare capabilities. VA officials noted that the technology had previously been used at a limited number of leading academic epilepsy centers and had not been used at a VA facility.
However, this single case does not document a nationwide rollout across all VA medical facilities. As the VA continues bringing complex neurological treatments into its own medical centers, will more veterans gain direct access to specialized epilepsy care without relying on outside academic institutions?
Follow BattleVet for practical guidance on military and veteran health, strength, recovery, testosterone, sleep and healthy aging. Stay connected for new articles, research backed insights and clear information to help you stay capable for the years ahead.
The RAF’s first functional fitness championships highlight a broader shift toward task-specific military training, emphasising capability and injury prevention.
A September 2026 Nature study found semaglutide extended median lifespan in female mice. We analyze the data alongside new VA peptide legislation and FDA actions.
Recent reporting highlights a potential association between military blast exposure and vascular brain conditions. Learn why tracking service history matters.
Build better habits around strength, recovery, sleep, hormones and healthy aging with practical guidance for active military personnel and veterans.
Explore BattleVet